Kiniksa Pharmaceuticals International Plc Earnings

Kiniksa Pharmaceuticals International Plc’s revenue jumped 64.95% since last year same period to $202.13Mn in the Q4 2025. On a quarterly growth basis, Kiniksa Pharmaceuticals International Plc has generated 11.76% jump in its revenue since last 3-months.

Kiniksa Pharmaceuticals International Plc’s net profit jumped 259.75% since last year same period to $14.2Mn in the Q4 2025. On a quarterly growth basis, Kiniksa Pharmaceuticals International Plc has generated -22.98% fall in its net profits since last 3-months.

Kiniksa Pharmaceuticals International Plc’s net profit margin jumped 196.85% since last year same period to 7.02% in the Q4 2025. On a quarterly growth basis, Kiniksa Pharmaceuticals International Plc has generated -31.08% fall in its net profit margins since last 3-months.

Kiniksa Pharmaceuticals International Plc’s earning per share (EPS) estimates for the current quarter stand at 0.32 - a -6.63% fall from last quarter’s estimates.

Kiniksa Pharmaceuticals International Plc’s earning per share (EPS) estimates for the current year stand at 0.32.

Kiniksa Pharmaceuticals International Plc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Kiniksa Pharmaceuticals International Plc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.